CA Patent

CA2688008A1 — Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position

Assigned to Kyorin Pharmaceutical Co Ltd · Expires 2008-11-27 · 17y expired

What this patent protects

[PROBLEMS] To provide a novel mutilin derivative substituted at the 14-position which shows a potent and broad antibacterial function on gram-positive bacteria and gram-negative bacteria including various drug-resistant bacteria and is expected as useful as a remedy for infectiou…

USPTO Abstract

[PROBLEMS] To provide a novel mutilin derivative substituted at the 14-position which shows a potent and broad antibacterial function on gram-positive bacteria and gram-negative bacteria including various drug-resistant bacteria and is expected as useful as a remedy for infectious diseases. [MEANS FOR SOLVING PROBLEMS] A mutilin derivative represented by the following general formula (1) or a pharmaceutically acceptable addition salt of the same.

Drugs covered by this patent

Patent Metadata

Patent number
CA2688008A1
Jurisdiction
CA
Classification
—
Expires
2008-11-27
Drug substance claim
No
Drug product claim
No
Assignee
Kyorin Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.